Joshua I. Rothman

Representative Matters

• Represented Bristol-Myers Squibb in Lek v. Bristol-Myers Squibb and Watson Laboratories (lipid-lowering pharmaceuticals)
• Represented GlaxoSmithKline in In Re 845 Patent Litigation, GlaxoSmithKline v. Dr. Reddy's, GlaxoSmithKline v. Cobalt Pharmaceuticals and GlaxoSmithKline v. Spectrum Pharmaceuticals (anti-migraine pharmaceuticals)
• Represented Warner-Lambert in Warner-Lambert Company v. Teva Pharmaceuticals (ACE inhibitor pharmaceuticals)
• Represented AstraZeneca in In Re Omeprazole Patent Litigation, AstraZeneca vs. Andrx, AstraZeneca v. GenPharm, AstraZeneca v. Dr. Reddy's, and AstraZeneca v. Kremer Urban Development Company (proton pump inhibitor pharmaceuticals)
• Represented Brigham and Women's Hospital, and Amgen Inc., in Brigham and Women's Hospital, et al. v. Barr and Teva (calcium receptor modulating pharmaceuticals)

Representative Clients

• Amgen
• Bristol-Myers Squibb
• Brigham and Women's Hospital
• Canon
• GlaxoSmithKline 
• Sanofi
• Warner-Lambert

Education

• J.D. Brooklyn Law School 1998
• M.S. Biomedical Engineering Rensselaer Polytechnic Institute 1994
• B.S. Inter-disciplinary Engineering University of Michigan 1993

Bar Admissions

• New York

Court Admissions

• U.S. District Court for the Southern District of New York
• U.S. District Court for the Eastern District of New York
• U.S. Court of Appeals for the Federal Circuit
• U.S. Supreme Court 2011

• Federal Circuit Bar Association
  • Recognized twice for his personal leadership and commitment in the Association’s Pro Bono, Veterans, and Personnel Pro Bono programs
  • Certificate of Appreciation (Awarded for devoted and invaluable services)
• Legal Aid Society, Outstanding Pro Bono Service
• Super Lawyers, Top Intellectual Property Litigator, New York Metro, 2015 – 2018

Pro Bono

• Active in the firm's pro bono practice and has helped clients obtain Section 8 housing, U-visas, and disability benefits